Varex Imaging (VREX) Total Non-Current Liabilities (2016 - 2026)
Varex Imaging's (VREX) quarterly Total Non-Current Liabilities came in at $553.1 million in Q2 2026, down 26.66% year-on-year from $754.2 million in Q2 2025, and down 0.88% on a QoQ basis from $558.0 million in Q1 2026.
Varex Imaging (VREX) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has 11 years of Total Non-Current Liabilities data on file, last reported at $553.1 million in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 26.66% year-over-year to $553.1 million in Q2 2026; TTM through Apr 2026 was $553.1 million, a 26.66% decrease from a year earlier, with the FY2025 full-year figure at $582.7 million, down 6.02% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $553.1 million, down from $558.0 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for VREX reached as high as $754.2 million in Q2 2025 and fell as low as $553.1 million in Q2 2026.
- Historically, Total Non-Current Liabilities has averaged $617.7 million across 5 years, with a median of $614.4 million in 2023.
- Across the five-year window, Total Non-Current Liabilities increased 21.76% in 2025 and declined 26.66% in 2026, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $616.1 million in 2022, then retreated by 0.28% to $614.4 million in 2023, then grew by 0.91% to $620.0 million in 2024, then slipped by 6.02% to $582.7 million in 2025, then decreased by 5.08% to $553.1 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $553.1 million in Q2 2026, $558.0 million in Q1 2026, and $582.7 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | - |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 3.53 Bn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 24.21 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | 3.57 Bn |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 9.85 Bn |
| 10 | Varex Imaging | 463.68 Mn | 375.38 Mn | 72.60 Mn | 553.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 553.10 Mn |
| Jan 2, 2026 | 558.00 Mn |
| Oct 3, 2025 | 582.70 Mn |
| Jul 4, 2025 | 564.70 Mn |
| Apr 4, 2025 | 754.20 Mn |
| Jan 3, 2025 | 737.50 Mn |
| Sep 27, 2024 | 620.00 Mn |
| Jun 28, 2024 | 614.30 Mn |
| Mar 29, 2024 | 619.40 Mn |
| Dec 29, 2023 | 614.40 Mn |
| Sep 29, 2023 | 627.00 Mn |
| Jun 30, 2023 | 623.10 Mn |
| Mar 31, 2023 | 615.30 Mn |
| Dec 30, 2022 | 616.10 Mn |
| Sep 30, 2022 | 603.90 Mn |
| Jul 1, 2022 | 602.60 Mn |
| Apr 1, 2022 | 594.50 Mn |
| Dec 31, 2021 | 600.90 Mn |
| Oct 1, 2021 | 619.20 Mn |
| Jul 2, 2021 | 640.90 Mn |